These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11717565)

  • 1. Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets.
    Moltz KC; Friedman AH; Nehgme RA; Kleinman CS; Carpenter TO
    Curr Opin Pediatr; 2001 Aug; 13(4):373-5. PubMed ID: 11717565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tertiary hyperparathyroidism during the treatment of familial hypophosphatemic rickets].
    Moreno Molina JA; López Siguero JP; Bueno Fernández A; Martínez-Aedo Ollero MJ; Martínez Valverde A
    An Esp Pediatr; 1996 Aug; 45(2):193-5. PubMed ID: 8967654
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.
    Alon U; Lovell HB; Donaldson DL
    Clin Pediatr (Phila); 1992 Mar; 31(3):180-3. PubMed ID: 1547591
    [No Abstract]   [Full Text] [Related]  

  • 4. Heart failure in hypophosphatemic rickets: complications from high-dose phosphate therapy.
    Sun GE; Suer O; Carpenter TO; Tan CD; Li-Ng M
    Endocr Pract; 2013; 19(1):e8-e11. PubMed ID: 23186962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
    Henley C; Colloton M; Cattley RC; Shatzen E; Towler DA; Lacey D; Martin D
    Nephrol Dial Transplant; 2005 Jul; 20(7):1370-7. PubMed ID: 15855208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
    Mäkitie O; Kooh SW; Sochett E
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):163-8. PubMed ID: 12580931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
    Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-existence of X-linked hypophosphatemic rickets (XLH) and primary hyperparathyroidism: case report and review of the literature.
    Tournis ST; Giannikou PV; Paspati IN; Katsalira EA; Voskaki IC; Lyritis GP
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):150-4. PubMed ID: 15951631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphatemic rickets, hyperparathyroidism, and hyperthyroidism with hypercalcemia.
    Wangel AG; Pannall P
    Aust N Z J Med; 1985 Oct; 15(5):650-3. PubMed ID: 3867343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets--application of the calcium infusion test as an indicator for parathyroidectomy.
    Alon U; Newsome H; Chan JC
    Int J Pediatr Nephrol; 1984 Mar; 5(1):39-43. PubMed ID: 6609135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
    Wu CJ; Song YM; Sheu WH
    Intern Med; 2000 Jun; 39(6):468-71. PubMed ID: 10852165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatemic rickets with sacroiliitis-like presentation in an adolescent.
    Onur O; Celiker R; Cetin A; Alikaşifoğlu A; Uğur O; Başgöze O
    Scand J Rheumatol; 1997; 26(4):332-5. PubMed ID: 9310118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism.
    Alon US; Monzavi R; Lilien M; Rasoulpour M; Geffner ME; Yadin O
    Pediatr Nephrol; 2003 Feb; 18(2):155-8. PubMed ID: 12579406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophosphatemic vitamin D refractory rickets and osteomalacia.
    Parfitt AM
    Orthop Clin North Am; 1972 Nov; 3(3):653-80. PubMed ID: 4344934
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.